Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for Verastem (VSTM) over the last 6 years, with Q3 2025 value amounting to $48.3 million.

  • Verastem's Other Non-Current Liabilities rose 8475.78% to $48.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.3 million, marking a year-over-year increase of 8475.78%. This contributed to the annual value of $58.2 million for FY2024, which is N/A changed from last year.
  • Per Verastem's latest filing, its Other Non-Current Liabilities stood at $48.3 million for Q3 2025, which was up 8475.78% from $21.8 million recorded in Q2 2025.
  • Over the past 5 years, Verastem's Other Non-Current Liabilities peaked at $58.2 million during Q4 2024, and registered a low of $51000.0 during Q3 2023.
  • Its 3-year average for Other Non-Current Liabilities is $34.9 million, with a median of $37.2 million in 2024.
  • In the last 5 years, Verastem's Other Non-Current Liabilities skyrocketed by 5115098.04% in 2024 and then soared by 8475.78% in 2025.
  • Quarter analysis of 3 years shows Verastem's Other Non-Current Liabilities stood at $51000.0 in 2023, then skyrocketed by 114015.69% to $58.2 million in 2024, then dropped by 17.02% to $48.3 million in 2025.
  • Its Other Non-Current Liabilities was $48.3 million in Q3 2025, compared to $21.8 million in Q2 2025 and $54.7 million in Q1 2025.